Lawmakers Review FDA’s Investigation Of J&J Stent

Law360, New York (August 14, 2007, 12:00 AM EDT) -- Two U.S. lawmakers have asked Johnson & Johnson for records relating to a 2004 warning letter it received from the U.S. Food and Drug Administration concerning its Cypher stent as it probes the agency's handling of the matter.

U.S. Rep. John Dingell (D-Mich.), chair of the House Committee on Energy and Commerce, and U.S. Rep. Bart Stupak (D-Mich.), chair of the Subcommittee on Oversight and Investigations, requested the records from J&J in a letter on Monday as they review how effective the FDA is in its...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.